CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Caladrius Biosciences, Inc.  (NBS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

NBS's Revenue Year on Year Growth by Quarter and Year

Caladrius Biosciences,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
NBS Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 10.18 7.56 5.28 4.08
III Quarter September 9.32 5.89 4.12 3.71
II Quarter June 8.30 5.87 4.49 4.36
I Quarter March 7.49 3.17 4.06 2.52
FY   35.29 22.49 17.95 14.67

Financial Statements
Caladrius Biosciences,'s forth quarter 2016 Revenue $ 10.18 millions NBS's Income Statement
Caladrius Biosciences,'s forth quarter 2015 Revenue $ 7.56 millions Quarterly NBS's Income Statement
NBS's Growth by Division See NBS's Growth by Segment

NBS Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December 34.61 % 43.18 % 29.41 % -
III Quarter September 58.23 % 42.96 % 11.05 % -16.25 %
II Quarter June 41.4 % 30.73 % 2.98 % 29.38 %
I Quarter March 136.28 % -21.92 % 61.11 % -88.58 %
FY   56.9 % 25.29 % 22.36 % -



NBS Revenue Growth Comment
Caladrius Biosciences, Inc. achieved in the forth quarter, above Company average Revenue growth of 34.61% year on year, to $ 10.18 millions.

Looking into forth quarter results within Biotechnology & Drugs industry 18 other companies have achieved higher Revenue growth. While Caladrius Biosciences, Inc.' s Revenue rise of 34.61% ranks overall at the positon no. 459 in the forth quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #19
Healthcare Sector #89
S&P 500 #459
Revenue Y/Y Growth Statistics
High Average Low
136.09 % 26.27 % -88.56 %
(Mar 31 2016)   (Mar 31 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NBS's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NBS's Competitors
Revenue Growth for Caladrius Biosciences,'s Suppliers
Revenue Growth for NBS's Customers

You may also want to know
NBS's Annual Growth Rates NBS's Profitability Ratios NBS's Asset Turnover Ratio NBS's Dividend Growth
NBS's Roe NBS's Valuation Ratios NBS's Financial Strength Ratios NBS's Dividend Payout Ratio
NBS's Roa NBS's Inventory Turnover Ratio NBS's Growth Rates NBS's Dividend Comparisons



Companies with similar Revenue rise for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Corcept Therapeutics Inc  59.09 %$ 59.090 millions
Momenta Pharmaceuticals Inc  52.70 %$ 52.704 millions
Djo Finance Llc  52.62 %$ 52.625 millions
Albany Molecular Research Inc  51.35 %$ 51.348 millions
Mri Interventions, Inc.  51.04 %$ 51.040 millions
Cutera Inc  50.03 %$ 50.027 millions
Dentsply International Inc  48.49 %$ 48.488 millions
Apollo Medical Holdings, Inc.  47.05 %$ 47.048 millions
Supernus Pharmaceuticals Inc  46.22 %$ 46.223 millions
Theravance Biopharma, Inc.  46.21 %$ 46.211 millions
Axogen, Inc.  46.10 %$ 46.099 millions
Stemline Therapeutics Inc  45.59 %$ 45.587 millions
Nephros Inc  45.42 %$ 45.419 millions
Amarin Corp Plcuk  45.29 %$ 45.293 millions
Inovio Pharmaceuticals, Inc.  43.44 %$ 43.440 millions
Integra Lifesciences Holdings Corp  43.13 %$ 43.130 millions
Amag Pharmaceuticals Inc.  39.41 %$ 39.412 millions
Great Basin Scientific, Inc.  39.23 %$ 39.234 millions
Cempra, Inc.  37.12 %$ 37.116 millions
Mimedx Group, Inc.  34.81 %$ 34.807 millions
Caladrius Biosciences, Inc.  34.61 %$ 34.612 millions
Lannett Co Inc  34.54 %$ 34.539 millions
Incyte Corp  33.88 %$ 33.876 millions
Abiomed Inc  33.66 %$ 33.660 millions
Teva Pharmaceutical Industries Ltd  33.01 %$ 33.006 millions
Heska Corp  32.87 %$ 32.874 millions
Adma Biologics, Inc.  32.46 %$ 32.456 millions
Biomarin Pharmaceutical Inc  32.08 %$ 32.080 millions
Combimatrix Corp  31.97 %$ 31.967 millions
Charles River Laboratories International Inc  31.92 %$ 31.917 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
JNFC's Profile
Stock Price
JNFC's Financials
JNFC's Expectations
Business Description
Fundamentals
Charts & Quotes
JNFC's News
Suppliers
JNFC's Competitors
Customers & Markets
Economic Indicators
JNFC's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com